Deep Integrated Network Analysis (DINA)

What is DINA?

At the heart of our transformative approach to healthcare lies our proprietary AI technology—Deep Integrated Network Analysis (DINA). Built on two decades of scientific innovation, DINA uniquely maps intricate disease mechanisms at a systems level, uncovering molecular relationships and interactions that traditional methods cannot capture.

A Data-Driven Approach

Unlike conventional approaches reliant on limited datasets, DINA integrates extensive single-cell RNA sequencing (scRNA-seq) data, precisely decoding complex cellular interactions, gene activities, and signaling pathways specific to each disease and patient.

Why Transcriptomics?

Our foundation is based on transcriptomic data, particularly single-cell RNA sequencing, which captures real-time, dynamic molecular changes at the cellular level. This approach addresses limitations in traditional genomic and proteomic methods, ensuring truly personalized medical insights.

Digital Twin Technology

Using DINA, we create Digital Twins—digital replicas of individual patients and diseases. These avatars enable clinicians to virtually test and compare hundreds of treatments, generating accurate, personalized drug recommendations in real time.

Integration of Public Biomedical Data

Our platform continuously integrates extensive publicly available biomedical datasets, ensuring comprehensive, diverse, and up-to-date molecular data. This vast pool of information forms the backbone of precise treatment personalization and innovative drug discovery.

• Mavatar Collabs:

A platform dedicated to pharmaceutical partnerships, enhancing drug development processes, drug validation, and treatment repurposing through targeted subgroup analyses and optimized patient stratification.

• Mavatar Discovery:

A turnkey SaaS platform offering comprehensive disease mapping and actionable insights for researchers and pharmaceutical companies. It supports biomarker discovery, drug target identification, and elucidation of biological mechanisms.
• Mavatar Precision:

A clinical decision-support tool providing real-time personalized treatment recommendations, optimizing clinical decisions based on patient-specific molecular profiles.

DINA’s comprehensive, data-driven insights empower healthcare providers to deliver precision medicine tailored specifically to the molecular uniqueness of each patient and their disease state, fundamentally transforming healthcare outcomes.